Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RespondWell was a digital health company focused on tele-rehabilitation and home-based physical therapy, particularly for post-surgical musculoskeletal patients such as total joint replacement recipients. Its platform delivered clinician-supervised rehabilitation programs in the home using interactive, game-like exercise workflows, patient monitoring, and communication tools intended to improve adherence and outcomes. The company marketed programs including Therapy@Home and Fitness@Home for remote rehabilitation and wellness engagement. RespondWell was acquired by Zimmer Biomet on October 27, 2016, and its technology was integrated into Zimmer Biomet Signature Solutions, after which RespondWell appears to have ceased operating as an independent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RespondWell.